Targeting tumor hypoxia and hypoxia-inducible factors (HIFs) for the treatment of cancer- A story of transcription factors with novel approach in molecular medicine

Curr Mol Med. 2022;22(4):285-286. doi: 10.2174/156652402204220325161921.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Basic Helix-Loop-Helix Transcription Factors / genetics
  • Basic Helix-Loop-Helix Transcription Factors / metabolism
  • Cell Hypoxia
  • Humans
  • Hypoxia / genetics
  • Hypoxia-Inducible Factor 1, alpha Subunit / genetics
  • Molecular Medicine
  • Neoplasms* / genetics
  • Neoplasms* / pathology
  • Neoplasms* / therapy
  • Transcription Factors*
  • Tumor Hypoxia

Substances

  • Basic Helix-Loop-Helix Transcription Factors
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Transcription Factors